Detalles de la búsqueda
1.
Duration of Adjuvant Aromatase-Inhibitor Therapy in Postmenopausal Breast Cancer.
N Engl J Med
; 385(5): 395-405, 2021 07 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-34320285
2.
Checkpoint inhibitors in metastatic gastric and GEJ cancer: a multi-institutional retrospective analysis of real-world data in a Western cohort.
BMC Cancer
; 22(1): 51, 2022 Jan 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35012477
3.
Landscape of HER2-low metastatic breast cancer (MBC): results from the Austrian AGMT_MBC-Registry.
Breast Cancer Res
; 23(1): 112, 2021 12 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-34906198
4.
Prognostic and Predictive Factors in Advanced Head and Neck Squamous Cell Carcinoma.
Int J Mol Sci
; 22(9)2021 May 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-34067112
5.
Combination Strategies for Immune-Checkpoint Blockade and Response Prediction by Artificial Intelligence.
Int J Mol Sci
; 21(8)2020 Apr 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-32325898
6.
MiR-1287-5p inhibits triple negative breast cancer growth by interaction with phosphoinositide 3-kinase CB, thereby sensitizing cells for PI3Kinase inhibitors.
Breast Cancer Res
; 21(1): 20, 2019 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30709367
7.
Radiologic complete response (rCR) in contrast-enhanced magnetic resonance imaging (CE-MRI) after neoadjuvant chemotherapy for early breast cancer predicts recurrence-free survival but not pathologic complete response (pCR).
Breast Cancer Res
; 21(1): 19, 2019 01 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-30704493
8.
HER2 Directed Antibody-Drug-Conjugates beyond T-DM1 in Breast Cancer.
Int J Mol Sci
; 20(5)2019 Mar 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-30841523
9.
Nonmetastatic pancreatic cancer : Improved survival with chemoradiotherapy >â¯40â¯Gy after systemic treatment.
Strahlenther Onkol
; 194(7): 627-637, 2018 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-29497791
10.
Ixazomib in combination with carboplatin in pretreated women with advanced triple-negative breast cancer, a phase I/II trial of the AGMT (AGMT MBC-10 trial).
BMC Cancer
; 18(1): 1074, 2018 Nov 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-30400780
11.
miR-16-5p Is a Stably-Expressed Housekeeping MicroRNA in Breast Cancer Tissues from Primary Tumors and from Metastatic Sites.
Int J Mol Sci
; 17(2)2016 Jan 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-26821018
12.
Clinical applications of next-generation sequencing-based ctDNA analyses in breast cancer: defining treatment targets and dynamic changes during disease progression.
Mol Oncol
; 2024 Jun 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-38867388
13.
Neratinib as Extended Adjuvant Treatment of HER2-Positive/HR-Positive Early Breast Cancer Patients in Germany, Austria, and Switzerland: Interim Results of the Prospective, Observational ELEANOR Study.
Breast Care (Basel)
; 19(1): 1-9, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38384488
14.
Updated Austrian treatment algorithm for metastatic triple-negative breast cancer.
Wien Klin Wochenschr
; 2023 Sep 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37682349
15.
Management of metastatic colorectal cancer in patients ≥70 years - a single center experience.
Front Oncol
; 13: 1222951, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37560467
16.
Pretreatment 18-FDG-PET/CT parameters can serve as prognostic imaging biomarkers in recurrent NSCLC patients treated with reirradiation-chemoimmunotherapy.
Radiother Oncol
; 185: 109728, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37301259
17.
Body composition dynamics and impact on clinical outcome in gastric and gastro-esophageal junction cancer patients undergoing perioperative chemotherapy with the FLOT protocol.
J Cancer Res Clin Oncol
; 149(7): 3051-3064, 2023 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-35864270
18.
Does the number of 6-monthly adjuvant zoledronate infusions received affect treatment efficacy for early breast cancer? A sub-study of ABCSG-12.
Eur J Cancer
; 180: 108-116, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36592505
19.
Updated Austrian treatment algorithm in HER2+ metastatic breast cancer.
Wien Klin Wochenschr
; 134(1-2): 63-72, 2022 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-35089396
20.
Transferring MINDACT to Daily Routine: Implementation of the 70-Gene Signature in Luminal Early Breast Cancer - Results from a Prospective Registry of the Austrian Group Medical Tumor Therapy (AGMT).
Breast Care (Basel)
; 17(1): 1-9, 2022 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-35355702